Use of CSF biomarkers in Alzheimer’s disease clinical trials

被引：0
|
作者：
K. Blennow
H. Zetterberg
机构：
[1] the Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Laboratory
[2] The Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Lab
[3] Sahlgrenska University Hospital,undefined
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
Mild Cognitive Impairment; Lewy Body Dementia; BACE1 Inhibitor; Secretase Inhibitor; Mild Cognitive Impairment Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?
    Frisoni, Giovanni B.
    Hansson, Oskar
    LANCET NEUROLOGY, 2016, 15 (07): : 650 - 651
  • [32] Comparing progression biomarkers in clinical trials of early Alzheimer's disease
    Cullen, Nicholas C.
    Zetterberg, Henrik
    Insel, Philip S.
    Olsson, Bob
    Andreasson, Ulf
    Blennow, Kaj
    Hansson, Oskar
    Mattsson-Carlgren, Niklas
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (09): : 1661 - 1673
  • [33] Use of Alzheimer Disease Biomarkers Potentially Yes for Clinical Trials but Not Yet for Clinical Practice
    Petersen, Ronald C.
    Trojanowski, John Q.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04): : 436 - 437
  • [34] CSF biomarkers in Alzheimer's disease (AD): Changes with CSF drainage
    Silverberg, G
    Saul, T
    McGuire, D
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S382 - S382
  • [35] Clinical use of biomarkers in the era of Alzheimer's disease treatments
    Vandevrede, Lawren
    Schindler, Suzanne E.
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
  • [36] Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease
    Zetterberg, Henrik
    Lunn, Michael P.
    Herukka, Sanna-Kaisa
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 371 - 376
  • [37] Longitudinal stability of CSF biomarkers in Alzheimer's disease
    Blennow, Kaj
    Zetterberg, Henrik
    Minthon, Lennart
    Lannfelt, Lars
    Strid, Stig
    Annas, Peter
    Basun, Hans
    Andreasen, Niels
    NEUROSCIENCE LETTERS, 2007, 419 (01) : 18 - 22
  • [38] Proteomic discovery of CSF biomarkers for Alzheimer's disease
    Zhang, Jing
    Montine, Thomas J.
    ANNALS OF NEUROLOGY, 2007, 61 (05) : 497 - 497
  • [39] Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
    Seppala, Toni T.
    Koivisto, Anne M.
    Hartikainen, Paivi
    Helisalmi, Seppo
    Soininen, Hilkka
    Herukka, Sanna-Kaisa
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (04) : 583 - 594
  • [40] Biomarkers for Alzheimer's disease therapeutic trials
    Hampel, Harald
    Wilcock, Gordon
    Andrieu, Sandrine
    Aisen, Paul
    Blennow, Kaj
    Broich, K.
    Carrillo, Maria
    Fox, Nick C.
    Frisoni, Giovanni B.
    Isaac, Maria
    Lovestone, Simon
    Nordberg, Agneta
    Prvulovic, David
    Sampaio, Christina
    Scheltens, Philip
    Weiner, Michael
    Winblad, Bengt
    Coley, Nicola
    Vellas, Bruno
    PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 579 - 593
12345